MONROVIA, Calif., April 9 /PRNewswire-FirstCall/ -- Staar Surgical Company (Nasdaq: STAA) announced today that it will webcast live its investor presentation at the American Society of Cataract and Refractive Surgery (ASCRS) symposium on Monday, April 14, 2003 beginning at 3:00 pm (PT). The webcast will be available to all interested parties through Staar Surgical's website, http://www.staar.com . To access the webcast, select the Financials section from Staar Surgical's home page and then select conference calls. Once on the conference call home page, select ASCRS Investor Webcast.

David Bailey, chairman and CEO, and John Bily, CFO of Staar Surgical will make a presentation about the Company and recent developments. This presentation will be followed by a roundtable discussion featuring Dr. John Vukich, Dr. Stephen Slade and Dr. R. Gale Martin, participants in the US FDA Clinical Trial of Staar Surgical's Implantable Contact Lens (ICL) and the Toric ICL.

About Staar Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the revolutionary Implantable Contact Lens as well as innovative products designed to improve patient outcomes for cataracts and glaucoma.

SOURCE  Staar Surgical Company
    -0-                             04/09/2003
    /CONTACT:  Investors, Douglas Sherk, +1-415-659-2285, or Jennifer Cohn,
+1-415-659-2289, or Media, Sheryl Seapy, +1-415-272-3323, all of EVC Group,
for Staar Surgical Company/
    /Web site:  http://www.staar.com /
    (STAA)

CO:  Staar Surgical Company; American Society of Cataract and Refractive
     Surgery
ST:  California
IN:  MTC HEA
SU:  CCA TDS



MP-ND 
-- SFW079 --
6490 04/09/2003 15:27 EDT http://www.prnewswire.com